# Insulet Corp: Form 10-Q for the period ended Mar 31, 2021

- Company: [Insulet Corp](/companies/podd.md) (CIK 1145197)
- Form: 10-Q
- Filed: 2021-05-07
- Accepted by EDGAR: May 6, 2021, 17:56 ET
- Period: 2021-03-31
- Accession: 0001145197-21-000016
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1145197/000114519721000016/podd-20210331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1145197/000114519721000016/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-01-01 to 2021-03-31 | $252.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2021-01-01 to 2021-03-31 | $84.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2021-01-01 to 2021-03-31 | $167.5m | us-gaap:GrossProfit |
| Research and development | 3 months, 2021-01-01 to 2021-03-31 | $40.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2021-01-01 to 2021-03-31 | $16.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2021-01-01 to 2021-03-31 | $13.6m | us-gaap:InterestExpense |
| Income tax | 3 months, 2021-01-01 to 2021-03-31 | $300.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-01-01 to 2021-03-31 | $0 | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2021-01-01 to 2021-03-31 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2021-01-01 to 2021-03-31 | $0.00 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2021-01-01 to 2021-03-31 | 66,113,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2021-01-01 to 2021-03-31 | −$35.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2021-01-01 to 2021-03-31 | $32.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2021-03-31 | $820.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-03-31 | $1.19bn | us-gaap:AssetsCurrent |
| Total assets | at 2021-03-31 | $1.84bn | us-gaap:Assets |
| Current liabilities | at 2021-03-31 | $185.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-03-31 | $1.25bn | us-gaap:Liabilities |
| Long-term debt | at 2021-03-31 | $1.05bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2021-03-31 | $15.7m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2021-03-31 | $585.3m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1145197/000114519721000016/podd-20210331.htm

Filed May 7, 2021.
Source: SEC EDGAR, the filing index for accession 0001145197-21-000016. Last ingested by Listed: Nov 14, 2026, 12:01 ET. No prices; not investment advice.
